A Comprehensive 4-Layered in Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS As a Novel Personalized Pre-Addiction Assessment Tool in the Opioid Crisis Era
Current pharmaceutical biotechnology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined